Alan Herschtal

Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study

Michael S. Hofman, Nathan Lawrentschuk, Roslyn J. Francis et al. · The Lancet · 2020 · 1.8K citations

Urology, Surgical Oncology, High-risk Prostate Cancer +12

Stereotactic ablative radiotherapy versus standard radiotherapy in stage 1 non-small-cell lung cancer (TROG 09.02 CHISEL): a phase 3, open-label, randomised controlled trial

David Ball, G Tao, Shalini Vinod et al. · The Lancet Oncology · 2019 · 569 citations

Adaptive Radiotherapy, Radiation Medicine, Radiation Therapy +9

Adjuvant radiotherapy versus early salvage radiotherapy following radical prostatectomy (TROG 08.03/ANZUP RAVES): a randomised, controlled, phase 3, non-inferiority trial

Andrew Kneebone, Carol Fraser‐Browne, Gillian Duchesne et al. · The Lancet Oncology · 2020 · 349 citations · Full text

Surgical Oncology, Urology, Radiation Therapy +10

Should extrapulmonary small cell cancer be managed like small cell lung cancer?

Sinéad Brennan, D. Gregory, Alison Stillie et al. · Cancer · 2010 · 193 citations · Full text

Online Adaptive Radiotherapy for Muscle-Invasive Bladder Cancer: Results of a Pilot Study

Farshad Foroudi, Jacky Wong, Tomas Kron et al. · International Journal of Radiation Oncology*Biology*Physics · 2010 · 148 citations

Adaptive Radiotherapy, Urology, Radiation Therapy +8